FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle

Business by 2FIRSTS, edited by Sophia
Mar.05.2024
FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Philippine Customs seized unregistered, unauthorized e-cigarette products worth 4 billion pesos, impacting Chinese brands like Romio and OXVA.

On the evening of February 29th, the Philippine Bureau of Customs Intelligence and Investigation Services seized a shipment of e-cigarette products valued at 4 billion pesos (approximately 510 million RMB, 70 billion USD) that were not registered in the Philippines and lacked the necessary authorization certificates. The confiscated FLAVA vape products are believed to have originated from the Philippines. (Read more: Breaking: Philippines Authorities Seize $70 Million's Flava Products)

 

Against this backdrop, 2FIRSTS had discussions with several individuals who are familiar with the e-cigarette market in the Philippines to understand the current situation of the market.

 

FLAVA is the leading distribution brand in the Philippines. It is understood that the Philippines has three major distribution companies, namely FLAVA, DENKAT, and SHIFT. Any brand looking to enter the Philippine market through these channels needs to establish a co-branding partnership with them. For example, the e-cigarette brand OXBAR (from OXVA) sold in the Philippines market carries the FLAVA brand logo on its product packaging and promotional materials.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
OXBAR products sold in the Philippines market come with the FLAVA logo | Image source: OXBAR

 

According to sources, the recent seizure of goods by FLAVA has had a significant impact on the Chinese companies they were working with. FLAVA did not fully pay for the goods they were purchasing, with some orders only paying 30% to 50%, and even as low as 20%. 

 

According to sources familiar with the e-cigarette market in the Philippines, Romio (from Shenzhen Maoanda Technology Co., Ltd. according to QCC) and OXVA (from Shenzhen Future Tech CO., Limited according to QCC), which have the closest cooperation with FLAVA, are considered the two Chinese brands most affected by this event. Among the products released on FLAVA's official social media platforms, Romio and OXBAR, a brand under OXVA, are the two brands with the highest frequency of appearance.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Romio products in collaboration with FLAVA | Image source: Filipino distribution website

 

Judging from FLAVA's social media account, the brands that are also associated with them include GEEK BAR, FLONQ, and NIMMBOX.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Image source: FLAVA social media account

 

Sources revealed that the e-cigarette market in the Philippines is currently in a state of extreme chaos. Some brands planning to enter the market are feeling uneasy, as they are facing difficulties in collecting payments from distributors, who are refusing their requests. 

 

Furthermore, with FLAVA experiencing heavy losses, the e-cigarette market in the Philippines is currently undergoing a period of restructuring. Distributor SHIFT is seizing this opportunity to aggressively expand its channel business and has launched a promotion offering a free motorcycle with the purchase of an e-cigarette. As a result, many industry insiders speculate that after FLAVA's decline, SHIFT could become the "new king." According to insiders, SHIFT was founded by Filipino real estate and casino businessmen, with strong backing.

 

2FIRSTS will continue to monitor the dynamics of the e-cigarette market in the Philippines and will provide updates on the 2FIRSTS mobile app and www.2firsts.com in a timely manner. Stay tuned for more information.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
The European Commission has clarified to 2Firsts that its proposed cardiovascular health checks would assess smoking, vaping and the use of smokeless nicotine products as part of patients’ medical histories. The Commission also said Member States may organise additional checks within their healthcare systems. In the same response, it pointed to JRC research on e-cigarettes, heated tobacco products and nicotine pouches that has fed into the evaluation of EU tobacco legislation.
Nov.09